Efficacy and safety of fluticasone furoate (FF)/vilanterol (VI) once daily (OD) for 24 weeks in persistent asthma

被引：0
作者：
O'Byrne, Paul M. [1 ]
Bleecker, Eugene R. [2 ]
Bateman, Eric D. [3 ]
Busse, William W. [4 ]
Woodcock, Ashley [5 ]
Forth, Richard [6 ]
Toler, Tom [7 ]
Jacques, Loretta [8 ]
Lotvall, Jan [9 ]
机构：
[1] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada
[2] Wake Forest Univ Hlth Sci, Ctr Genom & Personalized Med, Winston Salem, NC USA
[3] Univ Cape Town, Dept Med, Rondebosch, South Africa
[4] Univ Wisconsin, Dept Med, Madison, WI USA
[5] Univ Manchester, Sch Translat Med, Manchester, Lancs, England
[6] GlaxoSmithKline, Quantitat Sci Div, Res Triangle Pk, NC USA
[7] GlaxoSmithKline, Resp Med Dev Ctr, Res Triangle Pk, NC USA
[8] GlaxoSmithKline, Resp Med Dev Ctr, Uxbridge, Middx, England
[9] Univ Gothenburg, Krefting Res Ctr, Gothenburg, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Treatments; Asthma; -; management;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
3151
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The efficacy and safety of Fluticasone Furoate/Umeclidinium/vilanterol (FF/UMEC/VI) on cough symptoms in adult patients with asthma, a randomized double-blind, placebo-controlled, parallel group study: Chronic Cough in Asthma (COCOA) study
    Tagaya, Etsuko
    Shinada, Jun
    Nagase, Hiroyuki
    Terada-Hirashima, Junko
    Hojo, Masayuki
    Sugihara, Naruhiko
    Yagi, Osamitsu
    Tsuji, Mayoko
    Akaba, Tomohiro
    Masaki, Katsunori
    Fukunaga, Koichi
    Ohbayashi, Hiroyuki
    Chiba, Kaoru
    Hozawa, Soichiro
    Atsuta, Ryo
    Aoki, Yasuhiro
    Hiranuma, Hisato
    Gon, Yasuhiro
    Tanaka, Akihiko
    JOURNAL OF ASTHMA, 2025,
  • [42] The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma
    Kempsford, R. D.
    Bal, J.
    Baines, A.
    Renaux, J.
    Ravindranath, R.
    Thomas, P. S.
    RESPIRATORY MEDICINE, 2016, 112 : 18 - 24
  • [43] HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis
    Tripathy, Ita
    Levy, Arden
    Ratner, Paul
    Clements, Diane
    Wu, Wei
    Philpot, Edward
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2009, 20 (03) : 287 - 294
  • [44] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Ashley Woodcock
    Eugene R Bleecker
    William W Busse
    Jan Lötvall
    Neil G Snowise
    Lucy Frith
    Loretta Jacques
    Brett Haumann
    Eric D Bateman
    Respiratory Research, 12
  • [45] Effect of fluticasone furoate (FF)/vilanterol (VI) compared with VI on acute exacerbations of COPD (AECOPD): A post-hoc analysis by baseline airflow obstruction
    Leather, David
    Yates, Louisa
    Newlands, Amy
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [46] Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
    Woodcock, Ashley
    Bleecker, Eugene R.
    Busse, William W.
    Lotvall, Jan
    Snowise, Neil G.
    Frith, Lucy
    Jacques, Loretta
    Haumann, Brett
    Bateman, Eric D.
    RESPIRATORY RESEARCH, 2011, 12
  • [47] Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma
    Buhl, Roland
    Vinkler, Ilona
    Magyar, Pal
    Gyori, Zsuzsa
    Rybacki, Cezary
    Middle, Michelle Vivienne
    Escher, Armella
    Engelstaetter, Renate
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (06) : 404 - 412
  • [48] Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk
    Meltzer, Eli O.
    Lee, Jane
    Tripathy, Ita
    Lim, Junghee
    Ellsworth, Anna
    Philpot, Edward
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2009, 20 (03) : 279 - 286
  • [49] Economic benefit of fluticasone furoate (FF)/umeclidinium (UMEC)/vilanterol (VI) by baseline blood eosinophil (EOS) count in COPD in the UK - The IMPACT trial
    Ismaila, Afisi S.
    Shah, Dhvani
    Martin, Alan
    Kendall, Robyn
    Noorduyn, Stephen G.
    Dasari, Priyadarsini
    Risebrough, Nancy A.
    Compton, Chris
    Noorduyn, Stephen G.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [50] Pharmacokinetic (PK) analysis of fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) following triple therapy at two UMEC doses in healthy subjects
    Henderson, A.
    Allen, A.
    Gupta, A.
    Renaux, J.
    Brealey, N.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345